PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Total Current Liabilities (2019 - 2026)

PRF Technologies' (PRFX) quarterly Total Current Liabilities came in at $2.3 million in Q2 2026, up 1016.19% on a YoY basis from $210000.0 in Q2 2025, and down 3.97% quarter-over-quarter from $2.4 million in Q4 2025.

Analysis

PRF Technologies (PRFX) Total Current Liabilities (2019 - 2026) Analysis & Trends

PRF Technologies (PRFX) has reported Total Current Liabilities for 8 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Current Liabilities rose 1016.19% year-over-year to $2.3 million; the trailing twelve-month figure through Jun 2026 stood at $2.3 million (up 1016.19% YoY), and the FY2025 full-year result was $2.4 million, changed 0.04% from the prior year.
  • Total Current Liabilities slipped to $2.3 million in Q2 2026 per PRFX's latest filing, from $2.4 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $4.9 million in Q2 2024 and bottomed at $210000.0 in Q2 2025.
  • Historically, Total Current Liabilities has averaged $1.7 million across 5 years, with a median of $1.1 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Total Current Liabilities tumbled 95.71% in 2025, then soared 1016.19% in 2026.
  • Over 5 years, Total Current Liabilities stood at $1.1 million in 2022, then slumped by 37.5% to $665000.0 in 2023, then jumped by 267.22% to $2.4 million in 2024, then fell by 0.04% to $2.4 million in 2025, then dropped by 3.97% to $2.3 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $2.3 million, $2.4 million, and $210000.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 15.65 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 6.35 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 1.66 Bn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 883.19 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 4.54 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 283.66 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn 331.18 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 263.21 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 12.39 Mn
10 PRF Technologies 622,054.07 -10.31 Mn - 2.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.34 Mn
Dec 31, 2025 2.44 Mn
Jun 30, 2025 210,000.00
Dec 31, 2024 2.44 Mn
Jun 30, 2024 4.89 Mn
Mar 31, 2024 3.25 Mn
Dec 31, 2023 665,000.00
Sep 30, 2023 1.10 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.28 Mn
Dec 31, 2022 1.06 Mn
Sep 30, 2022 1.19 Mn
Jun 30, 2022 549,000.00
Mar 31, 2022 768,000.00
Dec 31, 2021 757,000.00
Sep 30, 2021 628,000.00
Jun 30, 2021 613,000.00
Mar 31, 2021 741,000.00
Dec 31, 2020 961,000.00
Jun 30, 2020 6.87 Mn
API Access

PRF Technologies Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PRFX&period=max&api_key=YOUR_API_KEY